Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Rosiglitazone, a drug used to treat type 2 diabetes, is associated with an increased risk of heart failure and death among older patients compared to a similar drug.

   

Today in Popular Press...keeping you current

Easily led ash-tray: Adolescent smokers prone to drug abuse
EurekAlert, 12/14/09

Higher Risk for Heart Disease and Diabetes Associated With Androgen Deprivation Therapy
ScienceDaily, 12/14/09

Type 2 diabetes prevention can be long term
Health and Age, 12/14/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address